Astral Shares Drop 6% as Board Approves Chemicals Demerger into Astral Chemie

The Quick Take

• Astral shares fell nearly 6% after the board approved demerging its chemicals business into newly incorporated Astral Chemie.
• The Composite Scheme also includes merging Al-Aziz Plastics into Astral, restructuring the overall group.
• Equirus Securities noted the demerger creates near-term stock overhang as investors assign separate multiples to each new entity.

Astral Ltd shares fell close to 6% after the company's board approved a composite restructuring scheme involving the demerger of its chemicals business into a newly incorporated entity called Astral Chemie, according to Economic Times Markets. The scheme simultaneously includes merging Al-Aziz Plastics into the parent Astral Limited, consolidating the plastics operations while spinning off chemicals. The news represents a significant structural change for Astral, which has been one of India's better-performing building materials companies with businesses spanning CPVC pipes, adhesives, and specialty chemicals for infrastructure and construction sectors.

The market's negative initial reaction to the demerger reflects a common pattern in Indian corporate restructurings: valuation uncertainty during the transition period before new entity multiples are established. Equirus Securities analysts specifically highlighted the near-term overhang, noting that investors must decide what earnings multiple to apply to each segment before the market settles on appropriate valuations. Historically, demergers in India — such as Piramal Enterprises or D-Mart parent Avenue Supermarts structural changes — have often recovered as analysts rebuild coverage and separate earnings models emerge. The chemicals business, if it can demonstrate consistent margins, may attract premium specialty chemicals multiples over the medium term.

Watch Astral's official demerger record date announcement and the timeline for shareholder and regulatory approvals, which will determine when Astral Chemie shares begin trading on exchanges. The key forward signal is whether Astral Chemie's standalone financial metrics post-listing justify a specialty chemicals re-rating versus the blended multiple that Astral carried before the demerger. The macro variable is the Indian specialty chemicals sector outlook: if government export promotion policies and domestic import substitution support margin improvement in chemicals, the demerger could unlock material value for Astral shareholders beyond what the initial stock drop reflects.

Synthesized from 1 source.